Type d'étude:
Numéro de l'étude:
Type de traitement:
Allogeneic
Maladies:
Acute Myeloid Leukaemia (AML)
Titre court:
Objectif principal:
The primary end points are: overall survival
Secondary end points are: progression-free survival, non-relapse mortality, incidence of relapse
Secondary end points are: progression-free survival, non-relapse mortality, incidence of relapse
Principaux critères d'inclusion:
Pays:
Investigateur principal:
Akshay Sharma
Coordinateur EBMT de l'étude:
Arnaud Dalissier
E-mail du coordinateur de l'étude:
arnaud.dalissier@upmc.fr